Jon Hamilton Jon Hamilton is a correspondent for NPR's Science Desk.
Jon Hamilton 2010
Stories By

Jon Hamilton

Doby Photography/NPR
Jon Hamilton 2010
Doby Photography/NPR

Jon Hamilton

Correspondent, Science Desk

Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience and health risks.

In 2014, Hamilton went to Liberia as part of the NPR team that covered Ebola. The team received a Peabody Award for its coverage.

Following the 2011 earthquake and tsunami in Japan, Hamilton was part of NPR's team of science reporters and editors who went to Japan to cover the crisis at the Fukushima Dai-ichi nuclear power plant.

Hamilton contributed several pieces to the Science Desk series "The Human Edge," which looked at what makes people the most versatile and powerful species on Earth. His reporting explained how humans use stories, how the highly evolved human brain is made from primitive parts, and what autism reveals about humans' social brains.

In 2009, Hamilton received the Michael E. DeBakey Journalism Award for his piece on the neuroscience behind treating autism.

Before joining NPR in 1998, Hamilton was a media fellow with the Henry J. Kaiser Family Foundation studying health policy issues. He reported on states that have improved their Medicaid programs for the poor by enrolling beneficiaries in private HMOs.

From 1995-1997, Hamilton wrote on health and medical topics as a freelance writer, after having been a medical reporter for both The Commercial Appeal and Physician's Weekly.

Hamilton graduated with honors from Oberlin College in Ohio with a Bachelor of Arts in English. As a student, he was the editor of the Oberlin Review student newspaper. He earned his master's degree in journalism from Columbia University, where he graduated with honors. During his time at Columbia, Hamilton was awarded the Baker Prize for magazine writing and earned a Sherwood traveling fellowship.

Story Archive

Wednesday

Alzheimer's resilience

  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5048855/nx-s1-817d0c85-51b0-4718-b278-e6d459682e87" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Monday

New insights into the brain's waste-removal system could one day help researchers better understand and prevent many brain disorders. Mihaela Rosu/Getty Images hide caption

toggle caption
Mihaela Rosu/Getty Images

Thursday

A study finds that psilocybin can desynchronize networks in the brain, potentially enhancing its plasticity. Sara Moser/Washington University School of Medicine in St. Louis hide caption

toggle caption
Sara Moser/Washington University School of Medicine in St. Louis

A prominent brain scientist took psilocybin as part of his own brain study

  • Download
  • <iframe src="https://www.npr.org/player/embed/g-s1-11501/nx-s1-d613551f-c1de-4725-8ed3-dba5b81e09b4" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Wednesday

A prominent brain scientist took psilocybin as part of his own brain study

  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-5020261/nx-s1-d613551f-c1de-4725-8ed3-dba5b81e09b4" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Wednesday

Illustration of a brain and genomic DNA on a dark blue particle background. Yuichiro Chino/Getty Images hide caption

toggle caption
Yuichiro Chino/Getty Images

Wednesday

New insights into the brain's waste-removal system could one day help researchers better understand and prevent many brain disorders. Andriy Onufriyenko/Getty Images hide caption

toggle caption
Andriy Onufriyenko/Getty Images

The brain has a waste removal system and scientists are figuring out how it works

  • Download
  • <iframe src="https://www.npr.org/player/embed/g-s1-6177/nx-s1-d78cda39-f219-474a-b8ee-191ccacd880a" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Tuesday

The brain has a waste removal system and scientists are figuring out how it works

  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-4924960/nx-s1-d78cda39-f219-474a-b8ee-191ccacd880a" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Thursday

This illustration shows how the thin film of sensors could be applied to the brain before surgery. Courtesy of the Integrated Electronics and Biointerfaces Laboratory hide caption

toggle caption
Courtesy of the Integrated Electronics and Biointerfaces Laboratory

Brain sensor

  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-4985906/nx-s1-ebf6b723-415f-4970-968a-d4bc3c055d3c" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Wednesday

A new study looks at the roles that African and European genetic ancestries can play in Black Americans' risk for some brain disorders. TEK Image/Science Photo Library/Getty Images hide caption

toggle caption
TEK Image/Science Photo Library/Getty Images

African ancestry genes may be linked to Black Americans' risk for some brain disorders

  • Download
  • <iframe src="https://www.npr.org/player/embed/g-s1-3978/1252991435" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Monday

Food and Drug Administration advisers are reviewomg the Alzheimer's drug Donanemab

  • Download
  • <iframe src="https://www.npr.org/player/embed/nx-s1-4994039/nx-s1-195deff3-9480-4ee5-b24f-1e1782b00f66" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Wednesday

Genetic analysis explores the influence of African ancestry in brain disease risk

  • Download
  • <iframe src="https://www.npr.org/player/embed/1252987494/1252991435" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Wednesday

In college, Amylyx cofounders Josh Cohen and Justin Klee dreamed of finding a treatment for diseases like ALS. When their drug's promise did not pan out, they pulled it voluntarily from the market. Amylyx Pharmaceuticals hide caption

toggle caption
Amylyx Pharmaceuticals

Lots of drug companies talk about putting patients first — but this one actually did

  • <iframe src="https://www.npr.org/player/embed/1251409920/1251419014" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Friday

When the boys spent a year in the same school, Sam did fine, but John struggled and had some noisy meltdowns. Jodi Hilton for NPR hide caption

toggle caption
Jodi Hilton for NPR

Thursday

Researchers reveal nearly every detail of a sand grain-sized bit of brain

  • Download
  • <iframe src="https://www.npr.org/player/embed/1250318615/1250321390" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Wednesday

A drug company will stop selling lucrative medicine to keep a promise to ALS patients

  • <iframe src="https://www.npr.org/player/embed/1250052869/1250052870" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Tuesday

This image shows a brain "assembloid" consisting of two connected brain "organoids." Scientists studying these structures have restored impaired brain cells in Timothy syndrome patients. Pasca lab, Stanford University hide caption

toggle caption
Pasca lab, Stanford University

Scientists restore brain cells impaired by a rare genetic disorder

  • <iframe src="https://www.npr.org/player/embed/1247900797/1247923236" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Sunday

Wednesday

Scientists found a way to restore brain cells impaired by a rare genetic disorder

  • <iframe src="https://www.npr.org/player/embed/1246923934/1246923935" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Tuesday

Lily Padula for NPR

In the womb, a brother's hormones can shape a sister's future

  • <iframe src="https://www.npr.org/player/embed/1240906149/1244482458" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Monday

How the sex of one fetus can affect its neighbors in the womb

  • <iframe src="https://www.npr.org/player/embed/1243433871/1243511508" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Thursday

Early in life, Sam (left) and John were much more similar than they may seem today. "They both did not wave, they didn't respond to their name, they both had a lot of repetitive movements," says their mother, Kim Leaird. Jodi Hilton for NPR hide caption

toggle caption
Jodi Hilton for NPR

These identical twins both grew up with autism, but took very different paths

  • Download
  • <iframe src="https://www.npr.org/player/embed/1242264274/1242721563" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Wednesday

Most caretakers of those with dementia need help navigating services, survey shows

  • Download
  • <iframe src="https://www.npr.org/player/embed/1239760991/1239760992" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Tuesday

NIH scientists, studying Havana syndrome patients, find no physical trace of harm

  • Download
  • <iframe src="https://www.npr.org/player/embed/1239388560/1239388561" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript